Published

Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
Date: 2022-04-05
Source: Crossref
DOI: 10.51126/revsalus.v4isup.271
PubMed: Unavailable

Authors

Lemos Martins Sofia Machado Brito-da-Costa Andreia Madureira-Carvalho Áurea Dinis-Oliveira Ricardo Jorge Dias da Silva Diana

Watch author

Topics and keywords

psilocin Depression Pharmacology Mechanism of Action Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms2022-04-05

Related papers

Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatmentEClinicalMedicine · 2025-11-30 Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-10-31 Potential Benefits of Psilocybin for Lupus Pain: A Case ReportCurrent Rheumatology Reviews · 2023-09-05 The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress DisorderDiva portal (Dalarna University Library) · 2019-12-31 Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30 Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31